NSCI is pleased to announce our successful IND application to the FDA that will enable clinical testing of a novel stem cell therapy for patients with age-related macular degeneration (AMD). In AMD, the retinal pigment epithelial cells (RPE) at the back of the eye degenerate, causing loss of …
Current News
Regenerative Eye Research- More Than Meets the Eye
Breakthroughs in Regenerative Eye Research Closer Than You Think RENSSELAER N.Y., June 08, 2018 – As the field of regenerative medicine has progressed to deliver breakthroughs throughout medicine; leading discoveries have been made in ophthalmology. A recent article published in Cell Stem Cell …
Students from Averill Park High School visit NSCI labs
A Molecular Biology class from Averill Park High School visited the labs at NSCI. These twenty-one 9th and 10th graders were able to learn from researchers, explore the lab and experience a range of scientific wet lab activities first hand. Leading the workshop, NSCI’s Dr. Thomas Kiehl …
Dr. Sally Temple on the “Dr. Oz Show” as an Authority on Stem Cell Research
RENSSELAER N.Y., February 13, 2017 – Neural Stem Cell Institute Scientific Director, Dr. Sally Temple will appear as a guest on the “Dr.Oz” show, airing Tuesday, February 14th. Dr. Temple was asked to participate on the show as a stem cell expert and the current President of the …
Dr.Temple one of First 30 Award Recipients of New Federal Research Program
RENSSELAER N.Y., February 10, 2017 – Neural Stem Cell Institute Scientific Director, Dr. Sally Temple is one of the first 30 recipients of the new R35 Research Program Award, which is designed to encourage creative research by enhancing funding stability. Awards were announced by the National …